Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
654 |
|
| Actual shortage: | 16 (2%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 547 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
2 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-22 | 2019-06-19 | 3944 |
| GEN-CLOZAPINE | 200MG | TABLET | Resolved | 2017-03-23 | 2017-11-15 | 4063 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2017-03-23 | 2017-04-04 | 4073 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2017-03-24 | 2018-10-20 | 4133 |
| MYLAN-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-03-31 | 2018-07-04 | 5005 |
| MYLAN-CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-31 | 2017-04-21 | 5009 |
| MYLAN-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2017-03-31 | 2018-07-04 | 5012 |
| MYLAN-METFORMIN | 500MG | TABLET | Resolved | 2017-03-31 | 2017-09-22 | 5016 |
| MYLAN-METFORMIN | 850MG | TABLET | Resolved | 2017-03-31 | 2017-09-22 | 5020 |
| MYLAN-METFORMIN | 850MG | TABLET | Resolved | 2017-03-31 | 2018-07-05 | 5025 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-31 | 2017-08-17 | 5028 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-31 | 2017-06-22 | 5034 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Resolved | 2017-03-31 | 2018-08-11 | 5042 |
| MYLAN-GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-04-04 | 2017-08-24 | 5301 |
| MYL-SILDENAFIL | 50MG | TABLET | Resolved | 2017-04-04 | 2018-08-23 | 5307 |
| MYLAN-RISEDRONATE | 35MG | TABLET | Resolved | 2017-04-04 | 2017-11-02 | 5310 |
| MYLAN-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-04-04 | 2017-07-17 | 5316 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-04-04 | 2017-09-08 | 5319 |
| MYLAN-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-04-04 | 2017-08-24 | 5322 |
| MYLAN-ALPRAZOLAM | 1MG | TABLET | Resolved | 2017-04-04 | 2017-08-24 | 5326 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |